Assembly Biosciences Announces Appointment of John McHutchison, AO, MD, as President and Chief Executive Officer

NEXT STORY
Adaptive Biotechnologies Executes Lease for New 100,000 Square Foot Corporate Headquarters, Tripling its Footprint in Seattle’s Growing Biotech Hub
PREV STORY
Affimed Reports Second Quarter 2019 Financial and Operational Results
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Assembly Biosciences Announces Appointment of John McHutchison, AO, MD, as President and Chief Executive Officer

NEXT STORY
Adaptive Biotechnologies Executes Lease for New 100,000 Square Foot Corporate Headquarters, Tripling its Footprint in Seattle’s Growing Biotech Hub
PREV STORY
Affimed Reports Second Quarter 2019 Financial and Operational Results
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Hyris Chalk Up Another Success Fighting COVID19, Providing Canadian Researchers and Medical Specialists With a New Test to Detect T-Cell Immune Response to SARS-CoV-2

author_avatar
NASDAQ Market News

Phase III PEMPHIX study shows Roche’s MabThera/Rituxan (rituximab) superior to mycophenolate mofetil in patients with pemphigus vulgaris

author_avatar
NASDAQ Market News

HOOKIPA Pharma to Present at SVB Leerink’s CybeRx Series Vaccine Forum

author_avatar
NASDAQ Market News